Scinovex
review Open AccessTop 1% cited

Post‐translational modifications and activation of p53 by genotoxic stresses

European Journal of Biochemistry · 2001 · Vol. 268(10) · pp. 2764–2772
Ettore AppellaCarl W. Anderson

Abstract

In unstressed cells, the tumor suppressor protein p53 is present in a latent state and is maintained at low levels through targeted degradation. A variety of genotoxic stresses initiate signaling pathways that transiently stabilize the p53 protein, cause it to accumulate in the nucleus, and activate it as a transcription factor. Activation leads either to growth arrest at the G1/S or G2/M transitions of the cell cycle or to apoptosis. Recent studies point to roles for multiple post-translational modifications in mediating these events in response to genotoxic stresses through several potentially interacting but distinct pathways. The approximately 100 amino-acid N-terminal and approximately 90 amino-acid C-terminal domains are highly modified by post-translational modifications. The N-terminus is heavily phosphorylated while the C-terminus contains phosphorylated, acetylated and sumoylated residues. Antibodies that recognize p53 only when it has been modified at specific sites have been developed, and studies with these reagents show that most known post-translational modifications are induced when cells are exposed to genotoxic stresses. These recent results, coupled with biochemical and genetic studies, suggest that N-terminal phosphorylations are important for stabilizing p53 and are crucial for acetylation of C-terminal sites, which in combination lead to the full p53-mediated response to genotoxic stresses. Modifications to the C-terminus inhibit the ability of this domain to negatively regulate sequence-specific DNA binding; additionally, they modulate the stability, the oligomerization state, the nuclear import/export process and the degree of ubiquitination of p53.

Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysCancer Research and TreatmentsAcetylationDNA damageUbiquitinPhosphorylationCell biologyDNA repairSUMO proteinAmino acidBiologyCell cycle checkpoint

MeSH terms

AnimalsBinding SitesDNADNA DamageDNA-Binding ProteinsHumansModels, BiologicalPhosphorylationProtein Processing, Post-TranslationalTranscription FactorsTumor Suppressor Protein p53Protein Structure, Tertiary

Funding

  • U.S. Department of Energy
  • Office of Science
Citations
1,073
FWCI
27.43
field-weighted impact
References
84
Percentile
100%
vs. same field & year
Citations per year
Cited by
Sirtuin Functions in Health and Disease
Molecular Endocrinology · 2007 · 473 citations
The complexity of p53 stabilization and activation
Cell Death and Differentiation · 2006 · 691 citations
Molecular mechanisms of cisplatin resistance
Oncogene · 2011 · 2,727 citations
The P53 pathway: what questions remain to be explored?
Cell Death and Differentiation · 2006 · 661 citations
References
CBP/p300 in cell growth, transformation, and development
Genes & Development · 2000 · 1,757 citations
The p53 pathway
The Journal of Pathology · 1999 · 1,303 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.